Attached files
| file | filename |
|---|---|
| EX-99.1 - EXHIBIT 99.1 - Asterias Biotherapeutics, Inc. | a50952191_ex991.htm |
UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (date of earliest event reported): September
29, 2014
Asterias
Biotherapeutics, Inc.
(Exact name of registrant as
specified in its charter)
|
Delaware |
000-55046 |
46-1047971 |
|
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
230 Constitution Drive
Menlo
Park, California 94025
(Address
of principal executive offices)
(650) 433-2900
(Registrant's telephone number,
including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
⃞ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
⃞ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
⃞ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
⃞ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Section 8 – Other Events
Item 8.01 Other Events
On September 29, 2014, we issued a press release announcing that on October 1, 2014, we will distribute 8,000,000 warrants to purchase common shares of BioTime, Inc. to holders of our Series A common stock who were holders of record on September 15, 2014. A copy of the press release is attached hereto as Exhibit 99.1.
Item 9.01 - Financial Statements and Exhibits.
|
Exhibit Number |
Description |
| 99.1 | Press Release Dated September 29, 2014 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
ASTERIAS BIOTHERAPEUTICS, INC. |
|||
|
|
|||
| Date: | September 29, 2014 |
By: |
/s/ Robert W. Peabody |
|
Chief Financial Officer |
|||
INDEX TO EXHIBITS
|
Exhibit Number |
Description |
| 99.1 |
Press Release Dated September 29, 2014 |